IDiyas

For the Inventor, By the Inventor

Maineville, OH, United States of America

Sophie Eva Bogdan

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 112(Granted Patents)


Location History:

  • Mainville, OH (US) (1996 - 1998)
  • Maineville, OH (US) (1995 - 2002)

Company Filing History:

goldMedal14 out of 17,164 
 
The Procter Gamble Company
 patents

Years Active: 1995-2002

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6486190 - 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability (2002-11-26),
2. 6436978 - Guanidinylamino heterocycle compounds useful as &agr;-2 adrenoceptor agonists (2002-08-20),
3. 6423724 - 7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists (2002-07-23),
4. 6391878 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2002-05-21),
5. 6306877 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-10-23),
6. 6225331 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-05-01),
7. 6172095 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-01-09),
8. 5916900 - 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 (1999-06-29),
9. 5804587 - 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor (1998-09-08),
10. 5716966 - 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 (1998-02-10),
11. 5691370 - 5-(2-imidazolinylamino)benzimidazole compounds useful as (1997-11-25),
12. 5576437 - 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 (1996-11-19),
13. 5541210 - 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 (1996-07-30),
14. 5478858 - 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 (1995-12-26),

Title: The Innovative Contributions of Sophie Eva Bogdan

Introduction

Sophie Eva Bogdan is a prominent inventor based in Maineville, Ohio. She has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. Her work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Among her latest patents are innovative compounds such as 5-(2-imidazolinylamino)-benzimidazole derivatives, which are noted for their use as α-adrenoceptor agonists with improved metabolic stability. Additionally, she has developed Guanidinylamino heterocycle compounds that are useful as α-2 adrenoceptor agonists.

Career Highlights

Sophie is currently employed at The Procter & Gamble Company, where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in advancing the understanding of adrenoceptor agonists and their applications.

Collaborations

Throughout her career, Sophie has collaborated with notable colleagues, including Thomas L. Cupps and Raymond Todd Henry. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Sophie Eva Bogdan's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…